These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22596351)

  • 1. Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators.
    Burger PB; Yuan H; Karakas E; Geballe M; Furukawa H; Liotta DC; Snyder JP; Traynelis SF
    Mol Pharmacol; 2012 Aug; 82(2):344-59. PubMed ID: 22596351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
    Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
    Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB
    Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355
    [No Abstract]   [Full Text] [Related]  

  • 7. Allosteric regulation in NMDA receptors revealed by the genetically encoded photo-cross-linkers.
    Tian M; Ye S
    Sci Rep; 2016 Oct; 6():34751. PubMed ID: 27713495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains.
    Karlov DS; Radchenko EV; Zefirov AN; Palyulin VA; Pentkovski VM; Zefirov NS
    Biochem Biophys Res Commun; 2012 Aug; 424(4):687-90. PubMed ID: 22789854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodil.
    Tomitori H; Suganami A; Saiki R; Mizuno S; Yoshizawa Y; Masuko T; Tamura Y; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K
    J Pharmacol Exp Ther; 2012 Oct; 343(1):82-90. PubMed ID: 22743575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.
    Temme L; Bechthold E; Schreiber JA; Gawaskar S; Schepmann D; Robaa D; Sippl W; Seebohm G; Wünsch B
    Eur J Med Chem; 2020 Mar; 190():112138. PubMed ID: 32070917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-dependent N-methyl-D-aspartate receptor amino-terminal domain conformations and modulation by spermine.
    Sirrieh RE; MacLean DM; Jayaraman V
    J Biol Chem; 2015 May; 290(20):12812-20. PubMed ID: 25829490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201.
    Schreiber JA; Müller SL; Westphälinger SE; Schepmann D; Strutz-Seebohm N; Seebohm G; Wünsch B
    Eur J Med Chem; 2018 Oct; 158():259-269. PubMed ID: 30218911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
    Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
    Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
    Masuko T; Kashiwagi K; Kuno T; Nguyen ND; Pahk AJ; Fukuchi J; Igarashi K; Williams K
    Mol Pharmacol; 1999 Jun; 55(6):957-69. PubMed ID: 10347236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.